Academic Journal
View in EDS
Linked Full Text

Assuring safety of fecal microbiota transplantation in the COVID‐19 era: A single‐center experience

Bibliographic Details
Title: Assuring safety of fecal microbiota transplantation in the COVID‐19 era: A single‐center experience
Authors: Tien‐En Chang, Kuei‐Chuan Lee, Pei‐Chang Lee, Yen‐Po Wang, Yi‐Tsung Lin, Hui‐Chun Huang, Jiing‐Chyuan Luo, Hsiang‐Ling Ho, Yi‐Hsiang Huang, Ming‐Chih Hou, Task Force for Precision Medicine in Gut Microbial Therapy
Source: JGH Open, Vol 7, Iss 11, Pp 765-771 (2023)
Publisher Information: Wiley, 2023.
Publication Year: 2023
Collection: LCC:Diseases of the digestive system. Gastroenterology
Subject Terms: COVID‐19, donor screening, fecal microbiota transplantation, multidrug‐resistant organism, SARS‐CoV‐2, Diseases of the digestive system. Gastroenterology, RC799-869
More Details: Abstract Background and Aim Fecal microbiota transplantation (FMT) is used to treat recurrent or refractory Clostridioides difficile infection (CDI). In the past, screening of fecal donors required surveillance of personal behavior, medical history, and diseases that could be transmitted by the blood or fecal–oral route. In addition, the exclusion of multidrug‐resistant organisms (MDROs) has been recommended since 2018. This task has become more complicated in the era of the coronavirus disease‐2019 (COVID‐19) pandemic. To prevent fecal transmission of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), it is crucial to commence screening for SARS‐CoV‐2, alongside other traditional tests. Our aim was to investigate whether hidden carriers of SARS‐CoV‐2 were enrolled for stool donation, and the status of the presence or incidence of MDRO during fecal donation in Taiwan. Methods Fecal products collected from March 2019 to December 2022 were tested for MDRO and nucleic acid amplification tests for SARS‐CoV‐2 using the pooling method. The period of fecal product collection crossed the time before and during the COVID pandemic in Taiwan. Results A total of 151 fecal samples were collected. The fecal products were tested using polymerase chain reaction (PCR) to detect SARS‐CoV‐2. The results were negative for all stocks. This was similar to the results of MDRO testing. The safety of FMT products has been guaranteed during the pandemic. Conclusion Our FMT center produced MDRO‐free and COVID‐19‐free products before and during the COVID‐19 outbreak in Taiwan. Our protocol was effective for ensuring the safety of FMT products.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2397-9070
Relation: https://doaj.org/toc/2397-9070
DOI: 10.1002/jgh3.12979
Access URL: https://doaj.org/article/e6a48d959a444d81bbb631578a2adaa0
Accession Number: edsdoj.6a48d959a444d81bbb631578a2adaa0
Database: Directory of Open Access Journals
FullText Links:
  – Type: other
    Url: https://resolver.ebsco.com:443/public/rma-ftfapi/ejs/direct?AccessToken=46EF944FB8A5A4F8829F&Show=Object
Text:
  Availability: 0
CustomLinks:
  – Url: https://doaj.org/article/e6a48d959a444d81bbb631578a2adaa0
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from Directory of Open Access Journals
    MouseOverText: View record from Directory of Open Access Journals
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=23979070&ISBN=&volume=7&issue=11&date=20231101&spage=765&pages=765-771&title=JGH Open&atitle=Assuring%20safety%20of%20fecal%20microbiota%20transplantation%20in%20the%20COVID%E2%80%9019%20era%3A%20A%20single%E2%80%90center%20experience&aulast=Tien%E2%80%90En%20Chang&id=DOI:10.1002/jgh3.12979
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.6a48d959a444d81bbb631578a2adaa0
RelevancyScore: 1000
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 1000.28259277344
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Assuring safety of fecal microbiota transplantation in the COVID‐19 era: A single‐center experience
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Tien‐En+Chang%22">Tien‐En Chang</searchLink><br /><searchLink fieldCode="AR" term="%22Kuei‐Chuan+Lee%22">Kuei‐Chuan Lee</searchLink><br /><searchLink fieldCode="AR" term="%22Pei‐Chang+Lee%22">Pei‐Chang Lee</searchLink><br /><searchLink fieldCode="AR" term="%22Yen‐Po+Wang%22">Yen‐Po Wang</searchLink><br /><searchLink fieldCode="AR" term="%22Yi‐Tsung+Lin%22">Yi‐Tsung Lin</searchLink><br /><searchLink fieldCode="AR" term="%22Hui‐Chun+Huang%22">Hui‐Chun Huang</searchLink><br /><searchLink fieldCode="AR" term="%22Jiing‐Chyuan+Luo%22">Jiing‐Chyuan Luo</searchLink><br /><searchLink fieldCode="AR" term="%22Hsiang‐Ling+Ho%22">Hsiang‐Ling Ho</searchLink><br /><searchLink fieldCode="AR" term="%22Yi‐Hsiang+Huang%22">Yi‐Hsiang Huang</searchLink><br /><searchLink fieldCode="AR" term="%22Ming‐Chih+Hou%22">Ming‐Chih Hou</searchLink><br /><searchLink fieldCode="AR" term="%22Task+Force+for+Precision+Medicine+in+Gut+Microbial+Therapy%22">Task Force for Precision Medicine in Gut Microbial Therapy</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: JGH Open, Vol 7, Iss 11, Pp 765-771 (2023)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Wiley, 2023.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2023
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Diseases of the digestive system. Gastroenterology
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22COVID‐19%22">COVID‐19</searchLink><br /><searchLink fieldCode="DE" term="%22donor+screening%22">donor screening</searchLink><br /><searchLink fieldCode="DE" term="%22fecal+microbiota+transplantation%22">fecal microbiota transplantation</searchLink><br /><searchLink fieldCode="DE" term="%22multidrug‐resistant+organism%22">multidrug‐resistant organism</searchLink><br /><searchLink fieldCode="DE" term="%22SARS‐CoV‐2%22">SARS‐CoV‐2</searchLink><br /><searchLink fieldCode="DE" term="%22Diseases+of+the+digestive+system%2E+Gastroenterology%22">Diseases of the digestive system. Gastroenterology</searchLink><br /><searchLink fieldCode="DE" term="%22RC799-869%22">RC799-869</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Abstract Background and Aim Fecal microbiota transplantation (FMT) is used to treat recurrent or refractory Clostridioides difficile infection (CDI). In the past, screening of fecal donors required surveillance of personal behavior, medical history, and diseases that could be transmitted by the blood or fecal–oral route. In addition, the exclusion of multidrug‐resistant organisms (MDROs) has been recommended since 2018. This task has become more complicated in the era of the coronavirus disease‐2019 (COVID‐19) pandemic. To prevent fecal transmission of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), it is crucial to commence screening for SARS‐CoV‐2, alongside other traditional tests. Our aim was to investigate whether hidden carriers of SARS‐CoV‐2 were enrolled for stool donation, and the status of the presence or incidence of MDRO during fecal donation in Taiwan. Methods Fecal products collected from March 2019 to December 2022 were tested for MDRO and nucleic acid amplification tests for SARS‐CoV‐2 using the pooling method. The period of fecal product collection crossed the time before and during the COVID pandemic in Taiwan. Results A total of 151 fecal samples were collected. The fecal products were tested using polymerase chain reaction (PCR) to detect SARS‐CoV‐2. The results were negative for all stocks. This was similar to the results of MDRO testing. The safety of FMT products has been guaranteed during the pandemic. Conclusion Our FMT center produced MDRO‐free and COVID‐19‐free products before and during the COVID‐19 outbreak in Taiwan. Our protocol was effective for ensuring the safety of FMT products.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 2397-9070
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: https://doaj.org/toc/2397-9070
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.1002/jgh3.12979
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/e6a48d959a444d81bbb631578a2adaa0" linkWindow="_blank">https://doaj.org/article/e6a48d959a444d81bbb631578a2adaa0</link>
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.6a48d959a444d81bbb631578a2adaa0
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.6a48d959a444d81bbb631578a2adaa0
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/jgh3.12979
    Languages:
      – Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 765
    Subjects:
      – SubjectFull: COVID‐19
        Type: general
      – SubjectFull: donor screening
        Type: general
      – SubjectFull: fecal microbiota transplantation
        Type: general
      – SubjectFull: multidrug‐resistant organism
        Type: general
      – SubjectFull: SARS‐CoV‐2
        Type: general
      – SubjectFull: Diseases of the digestive system. Gastroenterology
        Type: general
      – SubjectFull: RC799-869
        Type: general
    Titles:
      – TitleFull: Assuring safety of fecal microbiota transplantation in the COVID‐19 era: A single‐center experience
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tien‐En Chang
      – PersonEntity:
          Name:
            NameFull: Kuei‐Chuan Lee
      – PersonEntity:
          Name:
            NameFull: Pei‐Chang Lee
      – PersonEntity:
          Name:
            NameFull: Yen‐Po Wang
      – PersonEntity:
          Name:
            NameFull: Yi‐Tsung Lin
      – PersonEntity:
          Name:
            NameFull: Hui‐Chun Huang
      – PersonEntity:
          Name:
            NameFull: Jiing‐Chyuan Luo
      – PersonEntity:
          Name:
            NameFull: Hsiang‐Ling Ho
      – PersonEntity:
          Name:
            NameFull: Yi‐Hsiang Huang
      – PersonEntity:
          Name:
            NameFull: Ming‐Chih Hou
      – PersonEntity:
          Name:
            NameFull: Task Force for Precision Medicine in Gut Microbial Therapy
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 23979070
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: JGH Open
              Type: main
ResultId 1